Coalescent Surgical, Inc. Sustainability Profile
Coalescent Surgical, Inc., a leading innovator in the medical device industry, is headquartered in the United States. Founded in 2015, the company has rapidly established itself as a key player in the development of advanced surgical solutions, particularly in the fields of orthopaedics and minimally invasive surgery. Coalescent Surgical is renowned for its unique approach to surgical instrumentation, focusing on enhancing patient outcomes through precision-engineered products. Their flagship offerings include cutting-edge surgical tools and technologies designed to improve efficiency and safety in operating rooms. With a commitment to quality and innovation, Coalescent Surgical has achieved significant milestones, positioning itself as a trusted partner for healthcare professionals across major operational regions in North America and beyond. The company continues to push the boundaries of surgical technology, making a notable impact in the medical community.
DitchCarbon Score
How does Coalescent Surgical, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Coalescent Surgical, Inc.'s score of 50 is higher than 71% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Coalescent Surgical, Inc., headquartered in the US, currently does not have specific carbon emissions data available for recent years. The company is part of a merged entity with Medtronic plc, from which it inherits emissions data and climate commitments. As such, any climate-related initiatives or targets are aligned with those set by Medtronic plc. Coalescent Surgical has not publicly disclosed specific reduction targets or achievements. However, it is important to note that the climate commitments and initiatives are cascaded from Medtronic plc, which actively participates in various sustainability frameworks, including the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP). These initiatives aim to reduce emissions across all scopes, although specific figures for Coalescent Surgical are not provided. In summary, while Coalescent Surgical, Inc. does not have its own emissions data or reduction targets, it is aligned with the broader climate commitments of Medtronic plc, reflecting a commitment to sustainability within the medical technology industry.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 74,992,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 |
| Scope 2 | 269,008,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | 000,000,000 | 000,000,000 | - |
How Carbon Intensive is Coalescent Surgical, Inc.'s Industry?
How Carbon Intensive is Coalescent Surgical, Inc.'s Location?
Coalescent Surgical, Inc.'s Scope 3 Categories Breakdown
Coalescent Surgical, Inc.'s Scope 3 emissions, which increased by 48% last year and increased by approximately 48% since 2021, demonstrating supply chain emissions tracking. Most of their carbon footprint comes from suppliers and value chain emissions, with Scope 3 emissions accounting for 55% of total emissions under the GHG Protocol, with "Downstream Transportation & Distribution" being the largest emissions source at 47% of Scope 3 emissions.
Top Scope 3 Categories
Coalescent Surgical, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Coalescent Surgical, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
